- Home
- FINW vs CMPX Comparison
FINW vs CMPX Comparison
Compare FINW & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- CMPX
- Stock Information
- Founded
- FINW 1999
- CMPX 2014
- Country
- FINW United States
- CMPX United States
- Employees
- FINW N/A
- CMPX N/A
- Industry
- FINW Commercial Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- FINW Finance
- CMPX Health Care
- Exchange
- FINW Nasdaq
- CMPX Nasdaq
- Market Cap
- FINW 212.8M
- CMPX 214.6M
- IPO Year
- FINW 2021
- CMPX N/A
- Fundamental
- Price
- FINW $15.33
- CMPX $2.00
- Analyst Decision
- FINW Buy
- CMPX Strong Buy
- Analyst Count
- FINW 3
- CMPX 4
- Target Price
- FINW $18.67
- CMPX $13.75
- AVG Volume (30 Days)
- FINW 19.3K
- CMPX 1.8M
- Earning Date
- FINW 01-30-2025
- CMPX 11-12-2024
- Dividend Yield
- FINW N/A
- CMPX N/A
- EPS Growth
- FINW N/A
- CMPX N/A
- EPS
- FINW 1.06
- CMPX N/A
- Revenue
- FINW $69,509,000.00
- CMPX $850,000.00
- Revenue This Year
- FINW N/A
- CMPX N/A
- Revenue Next Year
- FINW $10.13
- CMPX $613.39
- P/E Ratio
- FINW $14.71
- CMPX N/A
- Revenue Growth
- FINW 4.87
- CMPX N/A
- 52 Week Low
- FINW $8.72
- CMPX $0.77
- 52 Week High
- FINW $20.50
- CMPX $2.68
- Technical
- Relative Strength Index (RSI)
- FINW 35.07
- CMPX 65.48
- Support Level
- FINW $15.51
- CMPX $1.43
- Resistance Level
- FINW $16.65
- CMPX $2.68
- Average True Range (ATR)
- FINW 0.71
- CMPX 0.24
- MACD
- FINW -0.07
- CMPX 0.06
- Stochastic Oscillator
- FINW 0.00
- CMPX 46.87
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.